Delcath Systems (FRA:DV3R) 3-Year EBITDA Growth Rate : 29.80% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Delcath Systems 3-Year EBITDA Growth Rate?

Delcath Systems's EBITDA per Share for the three months ended in Dec. 2023 was €-0.44.

During the past 3 years, the average EBITDA Per Share Growth Rate was 29.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 65.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Delcath Systems was 77.10% per year. The lowest was 29.80% per year. And the median was 76.00% per year.

Competitive Comparison of Delcath Systems's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Delcath Systems's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delcath Systems's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Delcath Systems's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Delcath Systems's 3-Year EBITDA Growth Rate falls into.

Delcath Systems 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Delcath Systems (FRA:DV3R) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Delcath Systems 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Delcath Systems's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Delcath Systems (FRA:DV3R) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Delcath Systems Inc (FRA:DV3R) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

DCTH:USA

Address

1633 Broadway, Suite 22C, New York, NY, USA, 10019

Website

https://www.delcath.com

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Delcath Systems (FRA:DV3R) Headlines

No Headlines